These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 1323786)

  • 1. Antibodies to hepatitis C virus (anti-HCV): prevalence in the same geographical area in dialysis patients, staff members, and blood donors.
    Malaguti M; Capece R; Marciano M; Arena G; Luciani MP; Striano M; Biagini M
    Nephron; 1992; 61(3):346. PubMed ID: 1323786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis C virus antibodies in hemodialysis patients in the area of Milan.
    Gubertini G; Scorza D; Beccari M; Buccianti G; Costantino A; Spotti D; Graziani G
    Nephron; 1992; 61(3):271-2. PubMed ID: 1323769
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of hepatitis C infection in a hemodialysis unit.
    Colombo P; Filiberti O; Porcu M; Costantini L; Mangione A; Monzeglio C; Peona C
    Nephron; 1992; 61(3):326-7. PubMed ID: 1323782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C virus in dialysis units: a multicenter study.
    Da Porto A; Adami A; Susanna F; Calzavara P; Poli P; Castelletto MR; Amici GP; Teodori T; Okolicsanyi L
    Nephron; 1992; 61(3):309-10. PubMed ID: 1323777
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of HCV antibodies in a uraemic population undergoing maintenance dialysis therapy and in the staff members of the dialysis unit.
    Besso L; Rovere A; Peano G; Menardi G; Fenoglio LM; Fenoglio S; Ghezzi PM
    Nephron; 1992; 61(3):304-6. PubMed ID: 1323775
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
    Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies against hepatitis C virus in hemodialysis patients in the central Italian region of Umbria: evaluation of some risk factors.
    Brugnano R; Francisci D; Quintaliani G; Gaburri M; Nori G; Verdura C; Giombini L; Buoncristiani U
    Nephron; 1992; 61(3):263-5. PubMed ID: 1323768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-hepatitis C virus in the elderly: a seroepidemiological study in a home for the aged.
    Floreani A; Bertin T; Soffiati G; Naccarato R; Chiaramonte M
    Gerontology; 1992; 38(4):214-6. PubMed ID: 1330832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of antibodies to hepatitis C virus in dialysis patients.
    Rivanera D; Lilli D; Lorino G; Pirozzi V; Cannulla V; Dicuonzo G; Mancini C
    Eur J Epidemiol; 1993 Jan; 9(1):55-8. PubMed ID: 7682515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The prevalence of antibodies to the hepatitis C virus (HCV) in patients with post-transfusional hepatitis and blood donors in Moldova].
    Iancu L; Turcu T; Apetrei C; Porumb S; Dimitriu S; Donţu G; Mândru R; Moraru E; Duca M
    Bacteriol Virusol Parazitol Epidemiol; 1993; 38(1-2):76-80. PubMed ID: 9132116
    [No Abstract]   [Full Text] [Related]  

  • 11. HCV seroprevalence in dialysis patients, their relatives and medical staff.
    Capşa D; Cernescu S; Constantinescu SN; Cernescu C
    Rev Roum Virol; 1991; 42(3-4):171-5. PubMed ID: 1667584
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of anti-HCV antibodies in hemodialysis patients.
    Fujiyama S; Kawano S; Sato S; Sato T; Shimada H; Matsushita K; Hara M; Ito J
    Gastroenterol Jpn; 1991 Jul; 26 Suppl 3():206-8. PubMed ID: 1909269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The prevalence of anti-HCV antibodies in a population of Sicilian hemodialysis patients].
    Soresi M; Montalto G; Galione A; Carroccio A; Bonfissuto G; Di Martino D; Annaloro R; Notarbartolo A
    Recenti Prog Med; 1994 Sep; 85(9):415-8. PubMed ID: 7938871
    [No Abstract]   [Full Text] [Related]  

  • 14. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T
    Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiology of hepatitis C in a population of hemodialysis patients.
    Mosconi G; Campieri C; Miniero R; Colì L; Orsi C; La Manna G; De Sanctis LB; Stefoni S; Sprovieri G; Bonomini V
    Nephron; 1992; 61(3):298-9. PubMed ID: 1323773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C: reality of a renal unit.
    Bracchi O; Orazi E; Lupi GP; Bronzieri C; Cornalba L; Grassi C
    Nephron; 1992; 61(3):369-70. PubMed ID: 1323795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of antibodies against hepatitis C virus in a dialysis unit.
    Cantù P; Mangano S; Masini M; Limido A; Crovetti G; DeFilippo C
    Nephron; 1992; 61(3):337-8. PubMed ID: 1323784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of antibodies to hepatitis C virus in hemodialysis units using a second generation assay.
    Mondelli MU; Cristina G; Piazza V; Cerino A; Villa G; Salvadeo A
    Nephron; 1992; 61(3):350-1. PubMed ID: 1323788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.